(1)
Novel Substituted 5-Arylidene-1, 3-Thiazolidin-4-One Analogues: Synthesis, Optimization, Anticancer Screening and Docking Studies. Journal of Pharmaceutical Negative Results 2022, 2378-2389. https://doi.org/10.47750/pnr.2022.13.S06.310.